Ever since Type A personality was linked to cardiovascular disease in the 1950s, it’s been known that anger raises the risk of heart attack and stroke. Now a Columbia study may explain how.
Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Columbia neuroscientists found that the mouse brain can direct the body's immune system to an unexpected degree, a discovery that could lead to new therapies for many immune disorders.
A new study reveals how bone marrow stem cell niche generation is regulated, which could lead to improvements in stem cell transplantation for the treatment of blood diseases.
Columbia bioengineers are the first to program bacteria that guide immune cells to tumors, which could make more cancers treatable with immunotherapies.
In his new role leading the Chan Zuckerberg Biohub New York, Andrea Califano will bring together scientists from several universities to engineer the immune system to detect and treat disease.
Columbia's Andrea Califano will lead the new Chan Zuckerberg Biohub New York in its mission to harness and engineer immune cells for the early detection and eradication of human disease.
A new study of sleep in women shows that delaying bedtime by just 90 minutes each night damages cells that line the blood vessels, supporting the hypothesis that poor sleep is linked to heart health.
Physician-scientist Neil Vasan brings the perspectives he's gained from classical singing and structural biology to his search for new breast cancer treatments.
Brief walks every hour can offset the harms of prolonged sitting—but who has time for that? With the help of an NPR podcast, researcher Keith Diaz is trying to identify, and break, the barriers.
A study of brain activity in courting zebra finches could help neuroscientists understand what happens in our brains when they shift gears as priorities and opportunities change.
Columbia researchers tracked how current language models, such as ChatGPT, mistake nonsense sentences as meaningful. Will analyzing their errors help us understand the way people think?
ADScreen, a speech-processing algorithm developed at Columbia Nursing, is now being tested in a clinical trial to see if it can help health care workers identify patients with Alzheimer's earlier.